- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Arginase 1 Antibody ARG1/1125 recognizes arginase 1 (ARG1), a cytosolic enzyme that catalyzes the hydrolysis of L-arginine into L-ornithine and urea. Encoded by the ARG1 gene on chromosome 6, this manganese-dependent enzyme is highly expressed in hepatocytes, where it performs the final step of the urea cycle. By converting ammonia-derived nitrogen into urea for excretion, ARG1 plays an essential role in nitrogen metabolism and maintaining metabolic homeostasis. The enzyme functions as a homotrimer, with individual subunits having a molecular weight of approximately 35 kDa.
Arginase 1 is an important diagnostic marker of hepatocellular differentiation and is widely used in immunohistochemistry to identify hepatocellular carcinoma (HCC). Its strong expression in normal hepatocytes and many hepatocellular tumors makes it valuable for distinguishing HCC from metastatic carcinomas and other primary liver malignancies. ARG1 is frequently evaluated alongside markers such as HepPar-1 and glypican-3 to improve diagnostic interpretation. Although highly associated with hepatocellular differentiation, ARG1 expression can vary in poorly differentiated tumors and is not entirely exclusive to hepatocellular tissue.
Beyond its hepatic functions, ARG1 participates in immune regulation through its effects on L-arginine availability. The enzyme is expressed in certain myeloid cell populations, including alternatively activated macrophages and myeloid-derived suppressor cells. Increased arginase activity can reduce extracellular arginine concentrations, potentially limiting T cell proliferation and effector function. ARG1 is therefore investigated in tumor-associated macrophages, immunosuppressive myeloid cells, and inflammatory conditions involving altered immune metabolism. However, ARG1 expression patterns differ between human and mouse myeloid populations, making species-specific interpretation important.
ARG1 also contributes to pathways involving polyamine synthesis, collagen production, and tissue repair through the generation of ornithine. Dysregulation of arginase activity has been studied in cancer, chronic inflammation, fibrosis, and metabolic disorders. Inherited ARG1 deficiency causes argininemia, a rare urea cycle disorder characterized by impaired arginine metabolism and progressive neurological complications. NSJ Bioreagents offers clone ARG1/1125, a monoclonal antibody supported by western blot, immunohistochemistry, and protein microarray validation. An Arginase 1 Antibody provides a useful tool for investigating hepatocellular differentiation, arginine metabolism, macrophage biology, and cancer-associated immune regulation.
Explore our selection of Cancer Marker Antibodies for investigating hepatocellular differentiation, tumor biomarkers, and protein expression in cancer research.
Optimal dilution of the Arginase 1 Antibody ARG1/1125 / ARG1 Monoclonal Antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
A recombinant fragment from amino acids 1-150 of human ARG1 was used as the immunogen for the Arginase 1 Antibody ARG1/1125.
Store the Arginase 1 Antibody ARG1/1125 at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
ARG1 antibody, Arginase I antibody, Liver Arginase antibody, Arginase Type 1 antibody, Hepatic Arginase antibody, Arginase-1 antibody, L-Arginine Ureohydrolase antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.